Status:
NOT_YET_RECRUITING
Comparative Evaluation of Body Temperature Measurement Using the CardioWatch 287-2 in an Intensive Care Setting.
Lead Sponsor:
Corsano Health B.V.
Conditions:
ICU Hospitalization
Surgical Intervention
Eligibility:
All Genders
18+ years
Brief Summary
Fever is a common symptom in many health conditions, but current methods to monitor body temperature (BT) are either invasive, costly, or not continuous. The Corsano CardioWatch 287-2, a wristband tha...
Detailed Description
Rationale Fever is one of the most common clinical symptoms. So far, clinically established methods to monitor body temperature (BT) are either invasive and expensive (blood, bladder or rectal cathete...
Eligibility Criteria
Inclusion
- ≥ 18 years old;
- Able to provide consent
- Administered at the ICU or recovery room of the Reinier de Graaf hospita
Exclusion
- Unable to wear the Corsano CardioWatch 287 or Radius-T sensor due to reasons such as allergic reactions, wounds, amputations etc.;
- Unable to receive rectal temperature monitoring;
- Thermoregulatory problems or diseases;
- Hyperthermia (\>40°C);
- Known allergy to plastics / latex;
- Patient not willing to sign informed consent;
- Significant mental or cognitive impairment.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06942338
Start Date
May 1 2025
End Date
September 1 2025
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reinier de Graaf Gasthuis
Delft, South Holland, Netherlands, 2625AD